
201 - 500 employees
Founded 2015
🧬 Biotechnology
💊 Pharmaceuticals
🔬 Science
💰 $175M Post-IPO Equity on 2021-10
Biotechnology • Pharmaceuticals • Science
Bicycle Therapeutics is a biotechnology company focused on developing precision-guided therapeutics to target intractable cancers and other serious diseases. Their mission is to create innovative medicines that have a transformative impact on patient lives by penetrating deep into tissues to address hard-to-target areas. While the company's primary focus is on solid tumor cancers, their technology also holds promise for a variety of therapeutic applications beyond oncology, such as anti-infective and cardiovascular treatments. Bicycle Therapeutics collaborates with pharmaceutical partners and academic leaders to explore new applications of their unique technology.
🔥 7 minutes ago
Applying expertise in in vivo pharmacology to evaluate Bicycle® Radio Conjugates. Independently executing preclinical studies to support advancement of next-generation cancer therapies.